Catheterization Lab Equipment

Neusoft Medical Systems Co., Ltd. is a global medical imaging equipment manufacturer headquartered in Shenyang, China, specializing in diagnostic imaging systems for hospital and clinical settings. The company designs, manufactures, and distributes a comprehensive portfolio of medical imaging equipment including CT scanners (including photon-counting CT technology), MRI systems, digital subtraction angiography (DSA) systems, X-ray systems, PET/CT systems, and ultrasound systems. Recent product launches include China's first photon-counting CT scanner with NMPA approval, representing advancement in imaging resolution and reduced radiation dose. Neusoft Medical operates globally across multiple regions including Europe, Middle East, North Africa, Latin America, and Central Asia, with a focus on affordable, accessible healthcare technology. The company provides comprehensive services including global customer support, equipment servicing, advanced medical technology training through dedicated training centers, and operates imaging diagnostic centers. The company also offers MDaaS (Medical Device as a Service) solutions for flexible healthcare delivery models. Founded in 2003, Neusoft Medical maintains regulatory approvals for international markets and participates actively in major medical equipment conferences including European Congress of Radiology (ECR), China International Medical Equipment Fair (CMEF), and Arab Health. The organization emphasizes clinical performance optimization and patient outcome improvement through innovation in imaging technology and intelligent ecosystem development.

Total Vein Systems is a medical device and consumables supplier specializing in vein surgery and interventional vascular procedures. Founded in 2003, the company markets an extensive product line of over 372 items including laser fibers, venous access devices, procedure packs, microphlebectomy instruments, compression hosiery, and surgical supplies. The TVS 1470 is their flagship open laser system featuring fibers with standard SMA connectors, designed for endovenous laser ablation and related minimally invasive vascular procedures. The company manufactures infiltration tubing kits and pump delivery systems with high-flow, large-bore configurations for rapid sterile solution delivery. All products are manufactured under ISO 13485 and KEMA standards, demonstrating commitment to medical device quality and regulatory compliance. Total Vein Systems emphasizes competitive pricing and customer service, positioning itself as a comprehensive single-source supplier for vein procedure requirements across clinical settings. The product portfolio addresses both procedural consumables and durable equipment needs for vascular surgery programs.

Abiomed is a leading manufacturer of percutaneous mechanical circulatory support systems, headquartered in Danvers, Massachusetts. The company specializes in the Impella family of heart pumps—catheter-based, minimally invasive devices designed to provide hemodynamic support and left ventricular unloading in acute heart failure, cardiogenic shock, and high-risk percutaneous coronary intervention (PCI) settings. Impella represents the world's smallest heart pump technology and is used to facilitate myocardial recovery and protect native heart function during complex cardiac procedures. The company's product portfolio includes multiple Impella configurations targeting different clinical scenarios, from acute myocardial infarction and cardiogenic shock to elective protected PCI in patients with severe coronary artery disease or advanced heart failure. Abiomed provides comprehensive clinical support services including on-site, on-call, and online technical and clinical assistance to healthcare professionals. The company maintains a global footprint with major operational centers in the United States (Danvers, Woburn, Baltimore), Europe (Aachen, Berlin), and Japan. Abiomed is a Johnson & Johnson MedTech company and operates within the cardiac support and interventional cardiology market. Clinical evidence demonstrates long-term survival benefits and myocardial recovery outcomes associated with Impella-supported procedures, supported by randomized controlled trials and registry data presented at major cardiology conferences.

AngioSystems is a U.S. manufacturing company specializing in radiation protection equipment and accessories for interventional cardiology and radiology departments. With over 40 years of innovation, the company designs and manufactures custom surgical drapes, radiation protection shields (SorbX line), pressure wedges, surgical trays, procedure packs, and radial access sleeves. Products are engineered specifically for cardiac catheterization laboratories and interventional radiology suites in leading hospitals worldwide. The SorbX radiation protection shield line has produced over one million units for major medical facilities. AngioSystems offers custom design capabilities to accommodate facility-specific requirements, including specialized trays for angiography, PICC line insertion, and other interventional procedures. The company emphasizes quality manufacturing, competitive pricing, and clinical solutions that improve patient outcomes—particularly radial access sleeves, which reduce procedure complications, enhance patient comfort, and accelerate hospital discharge while lowering institutional costs. Manufacturing is based in the United States.

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan, serving hospitals, surgical centers, and healthcare providers worldwide. The company manufactures and distributes a comprehensive portfolio of medical devices, surgical equipment, implants, and visualization systems across multiple specialties including orthopedics, neurosurgery, spine, trauma, cardiovascular, endoscopy, acute care, and emergency medicine. Key product categories include joint replacement implants (hips, knees) with Mako Robotic-Arm Assisted Technology, neurosurgical and spine instruments with 3D-printed technologies, minimally invasive surgical systems (laparoscopy, arthroscopy, endoscopy), emergency care equipment, communications systems for patient environments, interventional spine products (vertebroplasty, radiofrequency ablation), craniomaxillofacial solutions, sports medicine implants, and neurovascular stroke care devices. Stryker operates manufacturing facilities in multiple countries including Canada, China, and the US. The company maintains a strong commitment to sustainability through device reprocessing and remanufacturing services for single-use medical devices. With regional headquarters and distribution centers across the Americas, Europe, Asia-Pacific, and Middle East & Africa, Stryker provides integrated sales, service, and technical support. The company is regulated by the FDA and maintains global certifications for medical device manufacturing and quality management systems.

Viant Medical is a vertically integrated contract manufacturing partner specializing in medical device design, development, and full-scale production. The company operates 25 global locations with 2.3 million square feet of factory space, including 299,000+ square feet of ISO-certified clean room capacity. Viant serves OEMs across multiple clinical markets: orthopedics (instruments, implants, delivery systems, UHMWPE components), surgical technologies (minimally invasive surgery, robotics, endoscopy, ophthalmology, wound care, biopsy, aesthetic surgery), cardiac and interventional devices (overmolding, nitinol tubing, hypotube precision components), drug delivery (auto-injectors, IV sets, connectors, respiratory devices), bioprocessing (containment, transfer, filtration systems), bioelectronics (pain management, sleep apnea, wearables), diagnostics and laboratory products (injection tubes, chromatography tubing), and respiratory/monitoring/patient care (masks, trach tubes, airway tubes, console components). Core manufacturing capabilities include precision metals and metal tubing, medical-grade plastics and silicone molding, extrusions, tooling, automation, device assembly, and finished device services. The company provides end-to-end solutions from prototyping through sterilization and packaging management. Viant emphasizes vertical integration to ensure quality control, reduce supply chain risk, and accelerate time-to-market. The ViaLaunch™ program offers program management support. The company focuses exclusively on medical device manufacturing and maintains operational expertise in complex assembly, overmolding, and materials science.

Confluent Medical Technologies is a contract manufacturer specializing in design, development, and large-scale manufacturing of interventional catheter-based devices and implants. The company manufactures over 492,931 components annually across 400,000+ square feet of production capacity with 987+ employees and 98+ engineers. Core capabilities include precision Nitinol (nickel-titanium) components and tubing, high-precision polymer tubing (PTFE and polyimide), complex and balloon catheter systems, biomedical textiles (wovens, knits, braids, non-wovens, and electrospun materials), catheter components (sheaths, dilators), and polymer stent coverings. Products include Filmcast PTFE tubing (mandrel sizes 0.010"-0.137", wall thickness 0.0005"-0.002", 3-4 week lead times) and the recently launched Filmcast Select™ and Ultra Polyimide formulations for tailored performance. The company provides rapid prototyping, laser cutting and welding, design consultation, and testing services. Serves interventional cardiology, endovascular surgery, and other catheter-based device markets. Operates manufacturing facilities in Scottsdale AZ, Fremont CA, Orange County CA, Warwick RI, Windham ME, Austin TX, Chattanooga TN, and internationally in Costa Rica and India. Regulatory credentials and specific certifications not explicitly stated on provided content.

Voss Medical Products is a medical device developer and distributor specializing in single-use, disposable surgical products for operating room and procedural applications. The company distributes products under two primary licensing divisions: VM/Positioning and VM/Cardio Vascular. The VM/Positioning line includes specialty positioning devices designed to support patient positioning during prone procedures, spine surgery, cardiovascular vein harvesting, and airway management. Key products include The Prone Positioner™ (introduced 1985, the company's flagship product), The Leg Positioner™ for vein harvesting during coronary bypass, The Voss Supine™ for airway management during intubation, The Notch™ for securing nasal or oral RAE tubes, and laminectomy arm cradles. Recently expanded offerings include foam positioning products for obese patients: Prone XL™, Supine XL™, and Cardiac Leg Support XL™—all disposable, single-use devices. The VM/Cardio Vascular division manufactures devices specifically for coronary bypass procedures, including The Coronary Bypass Marker, The Coronary Bypass Clamp, and The Coronary Bypass Cannula. The company also manufactures The Disposable V-Scope™, a single-use laryngoscope combining precision with cost-effectiveness and disposability. All products are disposable, designed for strength and durability, and positioned as cost-effective alternatives to reusable devices. The Prone Positioner™ is priced 40% below comparable devices and requires no additional hardware. Company offers 100% satisfaction guarantee on all products.

Spirus Medical, LLC is a medical device manufacturer specializing in innovative gastrointestinal endoscopy and cardiology interventional devices. The company pioneered spiral endoscopy technology and currently manufactures over-tube systems for advanced endoscopic procedures. Primary product lines include the Endo-Ease Discovery® SB for small bowel enteroscopy and the Vista® Retrograde for colonoscopy—both utilizing proprietary rotate-to-advance technology that differentiates them in the market. In cardiology, Spirus offers the Dexterity™ Steerable Introducer, designed to provide physicians with proximal and distal tip steering capabilities for simplified cardiac access and anatomy navigation. The company serves gastroenterology and interventional cardiology specialists seeking advanced procedural access solutions. Based in West Bridgewater, Massachusetts, Spirus Medical focuses on bringing novel medical devices to market through engineering innovation. Contact available via phone and web form; specific regulatory certifications not explicitly detailed on website.

Chitogen Inc manufactures next-generation hemostatic products utilizing proprietary chitosan fiber technology to accelerate natural blood clot formation. The company's flagship product, the SoftSeal-STF (Surface Treated Fiber) Hemostatic Pad, is FDA-approved and designed for rapid hemostasis with improved patient comfort and reduced compression time. Chitogen products serve surgical, cardiovascular catheterization, and dialysis environments, offering patented technology that demonstrates proven improvement in time to hemostasis. The product line combines clinical efficacy with superior staff and patient satisfaction, addressing critical bleeding control needs across multiple clinical settings. The company emphasizes safety, speed, and ease of use in perioperative and interventional care applications.

Innovative Health LLC is a specialty medical device reprocessing company based in Scottsdale, Arizona, focused exclusively on cardiology electrophysiology (EP) devices. Founded in 2015, the company employs 99-106 people and generates approximately $15 million in annual revenue. Innovative Health utilizes advanced cleaning, testing, and inspection technologies to obtain FDA clearances for reprocessing complex single-use EP devices, including mapping catheters, diagnostic catheters, and other specialized electrophysiology equipment. The company's core service enables hospitals to reduce cardiology procedure costs by 30% or more—often saving over $3,000 per atrial fibrillation procedure—while maintaining FDA-determined safety and efficacy equivalence to new devices. Innovative Health offers a savings guarantee, conducts device utilization analyses, and provides optimized reprocessing programs. As a specialty reprocessor focused entirely on cardiology, the company achieves higher FDA clearance rates for complex technologies than generalist competitors, allowing hospitals to employ advanced medical technology at significantly reduced costs while freeing resources for improved patient care.

TT Medical USA, LLC is a leading supplier of advanced catheter technologies for interventional cardiology procedures. The company specializes in balloon catheter solutions designed to support hospitals and surgeons in delivering affordable, high-quality patient care. Their product portfolio includes proprietary balloon catheter systems for valvuloplasty, percutaneous transluminal coronary angioplasty (PTCA), and chronic total occlusion (CTO) interventions. TT Medical USA focuses on combining innovation with cost-effectiveness to meet the growing demand for accessible interventional cardiology equipment in hospital settings.

NuMED, Inc. is a 35+ year established manufacturer of innovative cardiovascular medical devices specializing in minimally invasive interventional solutions for congenital heart defects and peripheral vascular disease. The company manufactures over 26 interventional brands distributed across more than 100 countries globally. NuMED's comprehensive product portfolio focuses on pediatric interventional cardiology, including advanced balloon catheter systems, stent technologies, and catheterization lab equipment designed for diagnostic and therapeutic procedures. The company is committed to collaborating with global thought leaders and interventionalists to develop high-quality, clinically superior devices that improve patient outcomes in congenital heart treatment. With a strong presence in the international interventional community and founding sponsorship of PICS (Pediatric Interventional Cardiology Society) since 1997, NuMED combines decades of manufacturing expertise with ongoing innovation in catheter design, stent delivery systems, and hemodynamic interventional tools.

EPTAM Precision Solutions is a high-precision contract manufacturer specializing in close-tolerance machined and injection-molded components for mission-critical medical, aerospace & defense, and semiconductor applications. Founded in 1981 and headquartered in Northfield, New Hampshire, EPTAM serves the medical device industry with expertise in producing components for orthopedic implants, interventional cardiology devices, minimally invasive surgical instruments, and surgical robotics platforms. The company offers comprehensive capabilities including precision plastic injection molding, liquid silicone rubber (LSR) molding, metals machining, micro-machining, laser cutting and welding, and additive manufacturing. EPTAM provides integrated design-for-manufacturing (DFM) consultation, tooling development, production scaling, and quality assurance aligned with medical device regulatory standards. The company operates dedicated rapid prototyping facilities (READI) for fast-turn development and maintains approximately 152–500 employees. EPTAM partners with leading OEMs in biotech diagnostics, biopharma manufacturing, medical robotics, and implant sectors to accelerate time-to-market and ensure consistent product quality.

Q3 Medical USA, LLC is a subsidiary of Q3 Medical Group, an Irish medical device holding company specializing in the development, manufacturing, and global distribution of innovative minimally invasive and biodegradable medical devices. The company focuses on cardiology, peripheral vascular, and non-vascular applications, with particular expertise in biodegradable implants, micro-invasive technologies, and drug delivery platforms. Q3 Medical's flagship product, ARCHIMEDES, is the first fully biodegradable biliary and pancreatic stent, designed to eliminate the need for removal procedures while reducing complications and healthcare costs. Operating through subsidiaries in Germany, China, and the USA, the company employs a clinician-led, multidisciplinary approach to develop patient-centric solutions that streamline treatment pathways, reduce hospital stays, and lower overall healthcare expenses. The company is committed to advancing sustainable healthcare through innovative technologies that balance superior patient outcomes with economic and environmental benefits.

NeuWave Medical, Inc., a wholly owned subsidiary of Quantum Surgical, Inc., specializes in developing and commercializing energy-based minimally invasive microwave ablation systems for soft tissue treatment. The company's flagship NeuWave™ Microwave Ablation System is indicated for percutaneous, open surgical, and laparoscopic-assisted ablation of non-resectable liver tumors and soft tissue lesions. The system features ABLATE-IQ™ technology for pre- and post-ablation scan fusion and margin confirmation, Tissu-Loc™ technology using CO2 cooling to minimize probe migration, and a comprehensive probe portfolio including the PRS35 probe with 35cm length for enhanced anatomical reach. The system supports multi-probe synchrony (1–3 probes) to create larger, more spherical ablation zones tailored to individual patient anatomy. Having served over 100,000 patients worldwide, NeuWave continues to pioneer microwave ablation standards and deliver clinical support through live case assistance, virtual clinical concierge services, and comprehensive procedural guidance resources.

Yokowo Co., Ltd. is a Japanese electronic components and advanced devices manufacturer founded in 1922, headquartered in Tokyo with 23 global locations. The company specializes in antennas, fine connectors, microwave technologies, and test solutions serving wireless communication, automotive, semiconductor, and medical industries. In medical applications, Yokowo develops minimally invasive medical devices including OEM guidewires and catheters for interventional procedures, leveraging low-temperature co-fired ceramic (LTCC) technology and surface modification expertise. The company offers circuit testing connectors (CTC), vehicle communication antennas (VCCS), fine electronic connectors (FC), and medical devices (MD) divisions. Yokowo supports customers from R&D through production with emphasis on reliability, quality, and sustainability.

Spectrum Vascular is a medical device manufacturer founded in 2023, specializing in vascular access and medication management solutions with a focus on reducing catheter-related complications. The company develops a range of central venous catheters (CVCs), peripherally inserted central catheters (PICCs), midline catheters, and arterial lines incorporating proprietary antimicrobial and thromboresistant technologies. SV Spectrum™ Technology features antimicrobial catheters designed to prevent central line-associated bloodstream infections (CLABSI) and catheter-related bloodstream infections (CRBSI), validated by over 30 peer-reviewed studies. SV BioFlo Technology incorporates Endexo® surface-modifying macromolecules to minimize thrombus accumulation and catheter occlusions throughout the catheter's lifespan. Additional offerings include intraosseous (IO) needles, ECG-guided catheter placement systems, and accessory products. Spectrum Vascular's mission addresses the significant clinical and economic burden of vascular access infections and complications, with typical CRBSI treatment costs exceeding $45,000 per case.

Medtronic is a global healthcare technology leader serving 79+ million patients across diagnostic imaging, surgical and operating room equipment, intensive care, specialty medical, and homecare sectors. The company manufactures and distributes a comprehensive portfolio spanning cardiac rhythm and diagnostics systems, pacemakers, implantable cardioverter-defibrillators, deep brain stimulation devices, robotic surgery platforms, ventilators, anesthesia machines, infusion pumps, continuous glucose monitoring systems, insulin pumps, endoscopic and surgical navigation systems, and wound closure products. Recent FDA clearances include the Stealth AXiS surgical system for spine surgery and pulsed field ablation (PFA) technologies for atrial fibrillation treatment. Medtronic serves hospitals, surgical centers, critical care units, interventional labs, and home care settings through product lines in cardiac, vascular, neuromodulation, minimally invasive surgery, respiratory, and diabetes management. The company conducts 170+ active clinical trials, invests $2.7B annually in R&D, and holds FDA 510(k) clearances, CE marks, and ISO 13485 certification. Manufacturing and distribution capabilities span North America, Europe, and international markets with customer support available 24/7.

Boehringer Laboratories LLC is a US-based manufacturer of high-quality, precision medical devices serving hospital operating rooms, cardiothoracic programs, and surgical specialties. The company specializes in suction regulators, which have been industry-standard equipment for over 40 years, trusted by top hospital networks for precise vacuum pressure control during surgical procedures. The product portfolio includes the 7700, 7800, 3700, 3800, and 3900 Series Suction Regulators, designed to protect delicate tissues and ensure patient safety with multiple operating modes, accurate pressure settings, and durable, cleanable designs. Boehringer also manufactures the VAVD Controller and VacPac®, precision vacuum-regulation systems explicitly designed for vacuum-assisted venous drainage (VAVD) during cardiopulmonary bypass procedures, featuring redundant safety interlocks and positive interaction controls. The ViSiGi® device is a versatile gastric calibration and decompression system for bariatric surgery (sleeve gastrectomy and bypass), providing precise stomach sizing and enhanced surgical efficiency. CareDry® is an innovative female external catheter for urinary incontinence management, featuring 360-degree suction, antimicrobial foam, and moldable design for up to 48-hour wear. The company maintains factory-trained technical support, repair services (including out-of-warranty repairs), and a comprehensive service manual library. Boehringer operates from its Phoenixville, Pennsylvania headquarters and serves the US hospital market through a regional sales representative network, hospital departments including OR/Surgery, Perfusion, BioMed, Nursing, and Supply Chain. The company accepts orders via email, phone, fax, and credit card, with customer service responding within one business day.

Airiver Medical is a clinical-stage medical device company developing minimally invasive technologies for the treatment of respiratory tract conditions. The company's lead product candidate is a Drug Coated Balloon platform targeting two primary indications: central airway stenosis (including subglottic, tracheal, and bronchial stenosis) and chronic rhinosinusitis (CRS). Central airway stenosis is a common complication following lung transplantation, prolonged intubation, and tracheostomy, affecting 7–18% of post-transplant patients. CRS is one of the most prevalent chronic conditions globally, affecting approximately 39+ million people in the U.S., with approximately half requiring surgical intervention. Airiver's Drug Coated Balloon is designed to provide sustained airway patency and potentially reduce the need for repeat procedures. The company has secured FDA Investigational Device Exemption (IDE) approval for pivotal clinical trials in both indications and is led by experienced medtech executives with backgrounds at Boston Scientific, Lutonix, Entellus Medical, and other leading device manufacturers.

SkyDance Vascular manufactures the OspreyIV, a proprietary through-the-needle peripheral vascular access device designed to address complications associated with traditional over-the-needle catheters. The OspreyIV features four core innovations: (1) Skin Avoidance Technology—the catheter passes through rather than over the needle, preventing skin contact and reducing infection risk from bacterial colonization; (2) Bevel Only Technique—enabling single-attempt insertion success and minimizing vessel trauma and phlebitis; (3) Passive Needle Retraction—automatic needle retraction into housing post-insertion, eliminating sharps handling and needlestick injury risk; and (4) Contoured Directional Flow—off-axis fluid delivery away from the venous wall to reduce infiltration, phlebitis, and chemical irritation. The OspreyIV product line includes peripheral IV, peripheral closed IV, and midline closed IV catheter systems. Aligned with Aseptic Non-Touch Technique (ANTT) principles, the technology is designed to reduce catheter-related bloodstream infections (estimated 200,000 annually in the U.S., costing ~$6B), vessel damage, and clinical complications across adult, pediatric, and neonatal populations. B2B-focused supplier for hospitals, health systems, and acute-care facilities.

Minnesota MedTec is an FDA-registered, ISO 13485:2003-certified contract manufacturer specializing in precision medical device components and subassemblies. The company provides comprehensive outsourcing services including extrusion, molding, tube processing, and product assembly for interventional cardiology, radiology, neuroradiology, urology, and gastroenterology applications. Core capabilities encompass custom medical tubing, balloons, braided delivery systems, catheters, and molded polymer components manufactured from medical-grade resins. The company serves as a full-service partner from concept through commercialization, offering clean-room assembly, quality assurance, and regulatory compliance expertise. Minnesota MedTec's manufacturing processes include precision extrusion, injection molding, ultrasound tip forming, multi-durometer shafts, and specialized tube processing techniques to support minimally invasive medical device production.

Shanghai HeartCare Medical Technology Corporation Limited is a Chinese medical device innovator founded in 2016, specializing in neurointerventional solutions for acute ischemic stroke treatment and prevention. Headquartered in Shanghai Lingang New Area with R&D centers in Nanjing and California, the company has developed a comprehensive portfolio addressing unmet clinical needs in stroke management. The product pipeline includes thrombectomy systems, aneurysm and stenosis treatment devices, interventional access catheters, and stroke prevention instruments. With 34 registered medical device products, over 280 authorized patents, and presence in over 2,500 terminal hospitals across mainland China (excluding Macau), HeartCare is positioned as a pioneer in innovative interventional devices. The company holds Hong Kong listing status (stock code: 06609.HK) and maintains distribution channels covering all provincial administrative regions.

Provisio Medical, Inc. is a San Diego-based medical device company founded in 2014, specializing in intravascular ultrasound (IVUS) technology for endovascular interventions. The company has developed Sonic Lumen Tomography (SLT) IVUS, an FDA-cleared (510(k), 2024) system that provides real-time, automatic vessel flow lumen measurements without user input. The Provisio SLT IVUS System integrates ultrasound diagnostics directly into catheter-based procedures, enabling precise vessel sizing and visualization for guidewire placement and contrast delivery. This technology addresses critical gaps in peripheral vascular disease management, serving approximately 20 million U.S. patients with chronic and limb-threatening ischemia. By automating measurement workflows and eliminating traditional angiography limitations, Provisio Medical enhances procedural efficiency and clinical outcomes in endovascular therapy.

Medis Medical Imaging Systems is a Netherlands-based software company founded in 1989 as a spin-off from Leiden University Medical Centre. Specializing in vendor-independent, AI-powered cardiovascular image analysis software, Medis develops solutions for quantitative analysis across multiple imaging modalities including X-ray, CT, MRI, ultrasound, and intravascular imaging (IVUS/OCT). The company's flagship products include Medis QFR® (coronary physiology analysis via deep learning), Medis Suite MR (cardiac MRI post-processing), Medis Suite CT (cardiovascular CT quantification), Medis Suite XA (coronary and ventricular X-ray analysis), Medis Suite Ultrasound (cardiac deformation analysis), and Intravascular (IVUS/OCT post-processing). With ~126 employees globally and operations across 27+ countries, Medis serves hospitals, imaging centers, and research institutions. The company holds multiple patents and certifications; Medis QFR® has Class I recommendations in the 2024 ESC Guidelines for chronic coronary syndrome management. Medis emphasizes scientific rigor, clinical workflow efficiency, and user-oriented design in supporting cardiologists, radiologists, and researchers.

Flat Medical is a medical device company specializing in advanced solutions for epidural anesthesia and regional pain management. The flagship EpiFaith® Smart Syringe delivers real-time visual pressure sensing to support accurate epidural needle placement, significantly reducing procedural variability, wet tap complications, and postdural puncture headaches (PDPH). The company also offers the EpiFaith CV Syringe for safe central venous catheterization. Designed by clinicians and validated through clinical research, Flat Medical's products help standardize placement success across operators and are rapidly gaining adoption as a new standard of care in epidural procedures. The company partners with hospitals, academic institutions, and regional anesthesia specialists to advance patient safety and clinical confidence in pain management and anesthesia delivery.

Precipart is a global precision engineering manufacturer established in 1950, headquartered in Lyss, Switzerland, with additional facilities in Farmingdale (New York), London, and Ireland. The company specializes in high-precision custom mechanical components, gears, assemblies, and motion control systems serving the medical, aerospace, and industrial sectors. Precipart leverages advanced manufacturing capabilities including CNC machining, ceramic injection molding, and Swiss turning to deliver custom-engineered solutions for critical applications. In the medical sector, Precipart is recognized as a partner of choice for precision components and systems integration, with documented contributions to robotic surgery technologies and surgical instrumentation. The company serves as a full-service manufacturing partner, offering end-to-end capabilities from design and engineering through production and assembly for leading global companies requiring mission-critical precision components.

LightningCath is an ISO 13485-certified medical device manufacturer specializing in the design, prototyping, and manufacturing of high-quality catheter systems and components for minimally invasive procedures. Based in Brooklyn Park, Minnesota, the company operates an ISO 7 cleanroom facility and emphasizes rapid turnaround times to serve smaller medical device companies and healthcare professionals. LightningCath offers comprehensive catheter manufacturing services including design and prototyping, extrusion (single and multi-lumen thermoplastic and fluoropolymer tubing), injection molding, electrode assembly, and value-added services such as shape setting, tipping, micro-molding, crimping, and balloon bonding. The company supports applications across intravenous therapy, neurovascular interventions, and structural heart procedures, with capabilities ranging from low-to-high volume production and quick-turn development cycles.

ICHOR Vascular Inc. is a medical device manufacturer specializing in minimally invasive clot removal technology for peripheral vascular occlusions. The company develops the iSWEEP platform—an all-in-one endovascular thrombectomy and embolic protection system that modernizes the traditional Fogarty balloon sweep technique. The iSWEEP combines an occlusion balloon, expandable guide catheter with nitinol funnel, and rapid exchange balloon catheter into a self-contained, three-component system requiring no lytics, additional components, or capital equipment. FDA 510(k) cleared products include the iART 7F System for arterial applications and the iDVT 14F System for venous reperfusion. The technology treats vessel sizes from 4mm to 14mm and addresses both arterial and venous clot pathology. Designed for vascular interventionalists, iCHOR's systems aim to simplify peripheral clot removal while reducing procedural complexity, patient trauma, and operative cost compared to surgical thrombectomy or pharmacological thrombolysis.

CardioNXT, Inc. is a medical device company specializing in 3D mapping and navigation systems for treating cardiac arrhythmias, particularly chronic atrial fibrillation. Founded in 2012 and based in Westminster, Colorado, the company develops the iMap System—an electromagnetic tracking and AI-enabled mapping platform that integrates with leading catheter technologies from Boston Scientific, Medtronic, and Abbott, as well as CardioNXT's proprietary MultiLink CS Catheter. The iMap System supports next-generation pulsed field ablation (PFA) navigation with advanced features including contact detection, customized lesion tagging, and field scaling capabilities. CardioNXT enables zero-fluoroscopy 3D mapping procedures, reducing radiation exposure during cardiac electrophysiology interventions. The company has received FDA 510(k) clearance and holds seven patents in cardiac mapping and navigation technology.

RadScan Medical Equipment, Inc. is a manufacturer of patented Slicker® Protective Covers and Slicker® Cushion Table Pads designed to improve sanitation and reduce maintenance time and costs for hospitals and clinics. Founded in 1990 by biomedical engineer Tim Brown, the company has over 30 years of expertise in medical device accessories. RadScan's products feature proprietary vinyl films with welded seams that eliminate contamination hiding places and incorporate a patented flap system to prevent fluids from entering equipment internals. The covers extend the life of original equipment pads and cushions while being simple to install without affecting machine operations. Products are designed for CT scanners, angiography tables, nuclear medical equipment, and cardiac catheterization lab tables. ISO 13485 certified and FDA/EU MDR compliant, RadScan supplies hospitals, clinics, OEMs, and distributors worldwide through both direct sales and dealer networks.

Nanjing Devin Medical Technology Co., Ltd. is a National High-Tech Enterprise specializing in intelligent precision interventional therapy and minimally invasive ablation systems. Operating as a vertically integrated medical device manufacturer with R&D at its core, the company develops and manufactures MRI-compatible ablation systems, microwave ablation equipment, radiofrequency (RF) ablation closure systems, and interventional puncture consumables. With over 100 patents, a 12,000+ m² manufacturing facility, and collaborations with leading Chinese universities and research institutions, Devin Medical serves over 500 customers worldwide. The company provides ODM and OEM manufacturing capabilities for ablation products and integrated solutions. Applications include minimally invasive ablation procedures for solid tumors, benign nodules, respiratory interventional ablation, vascular interventional ablation, and surgical hemorrhoid treatment. The company is a member of the Jiangsu Medical Device Association and holds multiple innovation recognitions.

MAJiK Medical Solutions Pvt. Ltd. is an ISO 13485:2016 certified original equipment manufacturer (OEM) headquartered in Hyderabad, India, specializing in the design, development, and manufacturing of high-quality medical catheter tubing and related components for the global medical device industry. Operating from a 100,000 sq.ft. facility featuring ISO Class 7 and Class 8 clean rooms, dedicated white rooms for extrusion and heat-shrink operations, and ETO sterilization capabilities, MAJiK serves as a comprehensive single-source provider for sterile medical device manufacturing. The company manufactures a diverse portfolio including reinforced tubing (braided, coiled), specialty catheters (aspiration, guided, steerable, angiographic, micro), stent delivery systems, and custom tubing solutions tailored for cardiac electrophysiology, neurovascular interventions, and urology applications. MAJiK provides end-to-end services encompassing device design, component manufacturing, medical device assembly, packaging, and sterilization. With over 100 global customers and presence in multiple countries, the company emphasizes precision engineering, quality assurance, and compliance with international medical device standards.

Carmafil develops specialized surgical organization solutions for interventional and endovascular procedures. The company manufactures a unique guidewire bowl designed collaboratively by a dually-trained open/endovascular neurosurgeon and an accomplished engineer. This innovative product addresses a critical workflow challenge in catheterization labs and endovascular suites by preventing tangled catheters and guidewires—a persistent problem with conventional wire management systems. Carmafil's solution enables OR staff to maintain organized, efficient instrument management during complex minimally invasive procedures. The product is particularly suited for neurosurgical, vascular, and interventional radiology environments where precise guidewire and catheter handling is essential for procedural success.

Astute Imaging is a healthcare IT solutions company specializing in AI-powered cardiovascular imaging software for image-guided therapy and precision medicine. Founded in 2021 as a spin-off from Fivos Health, the company develops a cloud-based SaaS platform that integrates with EMR, PACS, and clinical registries. The platform automates surgery planning, device recommendations, vascular modeling and finite element analysis, and patient follow-up tracking. Astute Imaging serves healthcare providers and medical device manufacturers, supporting over 2,500 surgeons across 1,000+ centers. Key offerings include PEMS® (Patient Tracking and Management System), Preview® surgical planning tools, and proprietary finite element analysis for aortic disease management. The platform leverages 25 years of annotated vascular imaging data and AI to enhance diagnostic accuracy, provider productivity, and patient outcomes while reducing time-to-market for medical device development.

INVAMED is a Turkish medical device manufacturer headquartered in Ankara, founded in 2005, with operations spanning 15,000 m² and over 200 specialist employees. The company manufactures over 150 CE-marked medical devices across 23 product categories, exported to more than 80 countries with over 100 international patents. INVAMED specializes in cardiovascular and neurovascular interventional devices including coronary stents (ATLAS drug-eluting platform), mechanical thrombectomy systems (Mantis platform), and embolization devices (MultiBEAM vascular plugs, Spider coils, LIBRO EVOH liquid embolic agent). The company also produces comprehensive orthopedic implant solutions (CytroFIX system with intramedullary nails and locking plates), varicose vein treatment systems (VenaBLOCK, ThermoBLOCK, LaserBLOCK), aortic stent grafts (STENA MFM), and specialty devices for urology, ENT, pain management, dental implants (DENTURA), and digital health monitoring (RhythmTrack cardiac telemetry). All products comply with EU MDR 2017/745 and ISO 13485 standards. INVAMED maintains an in-house R&D center (INVAcenter) with 40+ biomedical engineers and has delivered over 500,000 device units since 2010.

HighLife Medical is a Paris-based medtech company founded in 2010, specializing in innovative transcatheter solutions for heart valve diseases, particularly mitral regurgitation. The company develops the HighLife TSMVR (Trans-septal Mitral Valve Replacement) system, a breakthrough device designed for patients with moderate to severe mitral regurgitation. This system enables trans-septal delivery on a beating heart, offering a minimally invasive alternative to traditional open-heart surgery for high-surgical-risk patients. HighLife has achieved significant regulatory milestones, including FDA Breakthrough Device Designation and CE Mark approval. The company operates with fewer than 25 employees across Europe, the USA, and Australia, with partnerships extending to China. Beyond device manufacturing, HighLife provides clinical support and physician training to enhance treatment accessibility and patient outcomes.

APQ Health develops FDA-cleared AI-powered software for automated quantitative analysis of 3D medical images, specializing in coronary plaque analysis from CT angiography. The company's flagship product, Autoplaque, provides deep learning–enabled quantification of coronary atherosclerosis, plaque characterization, and stenosis assessment. Backed by over 100 peer-reviewed publications and validation across 35 academic sites, including the landmark SCOT-HEART multicenter trial, Autoplaque demonstrates 95% agreement with invasive IVUS and ICC 0.95 correlation with expert readers. The software enables clinicians to quantify total plaque volume, identify low-attenuation (vulnerable) plaque burden, and predict patient-specific myocardial infarction risk. APQ Health's solution integrates clinical decision support with evidence-driven insights to improve cardiac risk stratification and patient outcomes.

R3 Vascular Inc. is an early-stage medical device company specializing in advanced bioresorbable vascular scaffolds (BVS) for treating peripheral arterial disease, particularly below-the-knee (BTK) blockages in patients with chronic limb-threatening ischemia. The company's flagship product, MAGNITUDE® Drug-Eluting Bioresorbable Scaffold, features a sirolimus coating that provides anti-inflammatory effects and fully resorbs over time to support vessel healing. R3 Vascular leverages proprietary polymer engineering and a unique manufacturing process utilizing ultra-high molecular weight polylactic acid. The company has secured FDA Investigational Device Exemption approval for its pivotal ELITE-BTK clinical trial, demonstrating commitment to rigorous clinical validation. R3 Vascular targets interventional cardiologists and vascular surgeons seeking innovative solutions for complex peripheral vascular disease management with bioresorbable technology that supports long-term vessel remodeling and healing.

SMD Manufacturing is a medical device manufacturer specializing in catheter stabilization and respiratory care solutions. The company designs and produces innovative devices that enhance patient safety and clinical outcomes in critical care settings. Their product portfolio includes non-invasive ventilation accessories and central venous catheter stabilization systems designed to reduce complications, improve workflow efficiency, and enable seamless patient care without interrupting ongoing therapy. SMD Manufacturing serves hospitals, ICUs, and respiratory care departments seeking reliable, evidence-based solutions for vascular access management and airway support.

NINGBO LINSTANT POLYMER MATERIALS CO., LTD is a specialized manufacturer of high-performance medical-grade polymer tubing and materials for minimally invasive surgical devices. Founded in 2014, the company focuses on extrusion processing, coating technology, and post-processing expertise for catheter and medical device applications. LINSTANT operates approximately 20,000 square meters of GMP-certified cleanroom manufacturing space in Ningbo, equipped with 15 precision extrusion lines, 8 dedicated PEEK extrusion lines, 2 injection molding lines, ~100 braiding/wrapping/coating systems, and 40 welding/forming units. The company specializes in fluoropolymer medical tubing (PTFE, FEP), polyimide (PI), PEEK, and advanced polymers for cardiovascular, neurological, urological, ophthalmological, endoscopic, and orthopedic applications. Core products include micro-catheters, guiding catheters, angiographic catheters, balloon tubing, negative-pressure sheaths, heat-shrink tubing, and customizable multi-layer/multi-lumen structures. The company provides OEM/ODM services including R&D design, rapid prototyping, testing/validation, regulatory assistance (ISO 13485 certified), and full-scale manufacturing for global medical device OEMs.

OPCOM Medical Inc. is an ISO 13485:2016 certified ODM/OEM manufacturer specializing in single-use disposable endoscopes and catheter solutions. Established in 2022 as a subsidiary of OPCOM Group (founded 1993), the company provides comprehensive turn-key solutions from system design, validation, and prototyping through high-volume cleanroom manufacturing. Capabilities span endoscope design, medical camera modules, catheter engineering (including braided, microcatheter, and steerable shafts), thermal bonding, laser welding, and complex sub-assemblies. The company serves cardiac electrophysiology, structural heart, urology, peripheral vascular, and general endoscopy markets. With R&D and manufacturing based in Taiwan and backed by 20+ years of industry experience, OPCOM Medical supports regulatory compliance including 510(k) applications and device validation, enabling customers to accelerate time-to-market for innovative medical devices.

X-Ray America is the exclusive US distributor for IAE, Europe's largest independent manufacturer of rotating anode x-ray tubes. The company supplies premium x-ray tube replacements for diagnostic imaging systems, offering 150+ models in stock and ready to ship. X-Ray America serves OEMs, biomedical engineers, and imaging service companies with replacement tubes for CT scanners, C-Arms, mobile radiography systems, mammography units, radiography/fluoroscopy systems, and angiography/catheterization lab equipment. Founded by diagnostic imaging veteran David Hurlock, the company emphasizes fast delivery and value pricing compared to OEM direct procurement. IAE tubes are certified to ISO 9001:2015 and 13485:2016, carry CE and cMETus marks, and are FDA-registered. The company combines IAE's 58+ year manufacturing heritage with US-based inventory and customer support for the diagnostic imaging replacement parts market.

Sunny Medical is a leading contract manufacturer of medical devices in China, specializing in plastic molding, assembly, packaging, and ETO sterilization services. The company offers SUNMED™ branded products, OEM, ODM, and customized medical device solutions to worldwide customers, with particular expertise in cardiology and radiology intervention products. Sunny Medical manufactures comprehensive PTCA surgery accessories including balloon catheters, inflation devices, guide wires, Y connectors, and related interventional devices. With ISO and CE certifications, the company has established distribution across more than 50 countries, primarily serving markets in the EU, Middle East, and other regions including Germany, Poland, Italy, Turkey, and Iran.

Lynn Medical is a family-owned specialty medical distributor based in Wixom, Michigan, with over 56 years of proven expertise serving the healthcare market. Founded in 1966, the company distributes diagnostic supplies and equipment with a focus on cardiology and imaging procedures. Lynn Medical serves more than 2,000 healthcare specialty practices, physician offices, clinics, hospitals, and laboratories nationwide. The company maintains partnerships with over 100 manufacturers and stocks more than 150,000 products, including cardiac catheterization equipment, ECG systems, patient monitoring devices, ultrasound supplies, electrodes, IV and infusion products, PPE, disinfection products, and point-of-care assays. With a team of 30+ clinical professionals offering technical expertise and consultation, Lynn Medical provides comprehensive solutions designed to improve patient management and reduce healthcare costs, backed by competitive pricing, reliable inventory management, and responsive customer service.

Quantum Surgical is a French medical robotics and AI company founded in 2017, specializing in robotic-assisted interventional oncology. Headquartered in Montpellier with a Miami office, the company develops and markets the Epione® robotic platform—a CE-marked and FDA 510(k)-cleared system designed for percutaneous tumor ablation in abdominal, chest, and musculoskeletal lesions. Epione integrates planning, navigation, targeting, and ablation confirmation into a single workflow, enabling minimally invasive treatment of early-stage and challenging tumors that are difficult to reach or surgically inaccessible. The platform has treated over 1,500 patients at 20+ cancer centers in Europe and North America. The Epione system standardizes access to ablation therapy, reducing procedural complexity while improving patient safety, reducing recovery time, and enabling outpatient procedures. Quantum Surgical also acquired NeuWave Medical, expanding its portfolio in thermal ablation technologies. With 130+ employees and recognition including the 2022 Prix Galien USA award, the company continues expanding market approvals and clinical installations.

Rapid Medical is an Israeli-based neurovascular medical device company specializing in innovative interventional tools for treating ischemic and hemorrhagic strokes. The company develops remotely adjustable, patient-anatomy-responsive devices that enable physicians to tailor endovascular procedures in real-time. With over 40,000 patients treated globally, 100+ issued patents, and 75+ clinical publications, Rapid Medical has established itself as a leader in neurovascular intervention. The company markets CE-marked devices including Pele, Comaneci, Bolt, TIGERTRIEVER 13, and DRIVEWIRE 24—all designed for mechanical thrombectomy, vessel remodeling, and aneurysm embolization. Recent clinical trials including the DISTALS trial demonstrate superior reperfusion outcomes in medium and distal vessel occlusions. With offices in Israel and the United States, Rapid Medical continues to expand its market presence in Europe and North America.

Cardio Flow, Inc. is a medical device manufacturer specializing in orbital atherectomy systems for the treatment of peripheral artery disease (PAD). The company's flagship product, FreedomFlow, is a modern atherectomy platform featuring diamond-coated rotating spheres designed to efficiently treat complex vascular lesions across a wide range of vessel diameters (2 mm to 8 mm). The platform offers multiple catheter configurations (5 Fr and 6 Fr variants with 3- or 5-sphere driveshafts), adjustable rotational speeds (50K–76K RPM), and single-device versatility for treating multiple blockages and vessel types from ankle to hip. FreedomFlow is designed for use in hospital operating rooms, ambulatory surgery centers, and office-based interventional labs, emphasizing workflow optimization, reduced capital costs, minimal inventory requirements, and rapid physician adoption with a shallow learning curve.

Nventric is a contract development and manufacturing organization (CDMO) specializing in end-to-end medical device design, development, and manufacturing for the neurovascular, electrophysiology, and coronary markets. The company serves as a strategic partner to medical device OEMs, providing comprehensive solutions from concept through volume production. Nventric's capabilities span innovative design services, advanced prototyping, rigorous testing, clinical design inputs, and full manufacturing support with ISO 13485 certification. The company develops a broad range of interventional devices including revascularization devices, catheters (balloon, guide, aspiration, diagnostic, and ablation), drug-eluting stents, hemostasis valves, and peripherally inserted central catheters (PICCs). Nventric's focus on complex vascular anatomy navigation and energy delivery systems positions it as a specialized partner for treating vascular diseases across multiple clinical applications.

Agile Devices is a Boston-based medical device development company specializing in innovative steerable and deflectable catheter technologies for interventional procedures. The company's flagship product, the Angler® microcatheter, features active tip control technology that enables clinicians to adjust the catheter tip angle in situ during procedures. This proprietary design reduces the need for device exchanges, thereby minimizing procedure time, radiation exposure, cost, and procedural risk. The technology is particularly valuable in interventional radiology, cardiology, and neuroradiology applications where vessel navigation challenges—such as tortuosity, acute branch angles, and atherosclerotic disease—are common. FDA-cleared for peripheral and coronary vascular use, Agile Devices' steerable microcatheters address critical clinical gaps in catheter navigation, improving outcomes in complex vascular interventions including embolization procedures and coronary angiography.

Bridgemed Solutions is a leading Contract Manufacturing Organization (CMO) specializing in transcatheter heart valve design, development, and manufacturing. The company custom-manufactures Transcatheter Aortic Valves (TAVR), Transcatheter Mitral Valves (TMVR), and Transcatheter Tricuspid Valves from tissue to finished device per client intellectual property. Beyond manufacturing, Bridgemed provides integrated consulting and strategic services across biocompatibility testing, ISO 22442 compliance, sterilization, viral inactivation qualification, quality management systems (QMS), regulatory submissions, and first-in-human (FIH) clinical trial support. The firm manufactures bovine and porcine tissue patches (glutaraldehyde-fixed) for the transcatheter heart valve industry and collaborates with partners on stent and delivery system development. Staffed by PhD scientists, tissue engineers, and skilled technicians, Bridgemed functions as an R&D extension for medical device companies, delivering customized, cost- and time-optimized solutions without unnecessary scope expansion.

Keya Medical is an international medical technology company founded in 2016, headquartered in Beijing with offices in Seattle, Shanghai, and Shenzhen. The company specializes in deep learning-based AI solutions for non-invasive disease diagnosis and treatment, with primary focus on cardiovascular care. Keya Medical develops AI-enabled diagnostic devices that enhance efficiency, accuracy, and precision in healthcare across cardiology, neurology, pulmonology, pathology, and surgery. The flagship product, DEEPVESSEL FFR, is a CT-derived fractional flow reserve (CT-FFR) analysis software that received FDA clearance (2022), CE marking (2018), NMPA approval (2020), and HSA certification (2023). This non-invasive tool reduces unnecessary invasive testing, improves patient safety, and lowers cardiovascular diagnostic costs. The company has secured over $111.74 million in funding and holds 11 registered patents related to artificial neural networks and medical imaging. Keya Medical established the first AI diagnostic laboratory and maintains collaborations with hospitals and key opinion leaders globally.

VascuTech Medical is an FDA and ISO 13485 registered medical device manufacturer specializing in vascular access devices for interventional radiology, interventional cardiology, pain management, and urology. The company manufactures Class I, II, and III devices including catheters (dialysis, balloon angiography, drug delivery), dilators, sheaths, hemostasis valves, biopsy needles, trocars, tunnelers, and thrombectomy devices. VascuTech provides comprehensive contract manufacturing services spanning product and process development, design engineering, rapid prototyping, pilot production, and full-scale manufacturing. The company maintains vertically integrated in-house fabrication and assembly capabilities with thirty years of combined experience in medical device design and development.

Endovascular Engineering, Inc. (E2) is a clinical-stage medical device company based in Menlo Park, California, specializing in advanced mechanical thrombectomy solutions for venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT). Founded in 2019 by Dr. Luis Savastano and backed by approximately $42 million in venture funding, E2 has developed the Hēlo™ PE Thrombectomy System—a minimally invasive catheter-based device designed to safely and effectively remove blood clots from the lungs. The Hēlo system features a unique self-expanding funnel design that delivers large-bore clot engagement through a small-profile catheter, reducing vascular trauma and hemodynamic compromise. Its dual-action technology combines high-speed mechanical agitation with simultaneous physician-controlled aspiration for single-pass clot disruption and removal. The system received FDA Investigational Device Exemption approval in January 2024 and is currently in pivotal clinical trials. E2 targets underserved peripheral VTE indications and aims to redefine the standard of care in endovascular thrombectomy.

EnsiteVascular is a specialized medical device manufacturer focused exclusively on vascular closure solutions for catheter-based cardiovascular procedures. The company develops and markets the SITESEAL® and SITESEAL SV™ device families—FDA-cleared, non-implant vascular closure devices designed for electrophysiology (EP), interventional cardiology, and structural heart procedures. SITESEAL® is engineered for arterial and venous access closure across all sheath sizes, including large-bore interventions (EVAR, TEVAR, TAVI), offering hemostasis without leaving foreign material behind. Key differentiators include no sheath size limitations, closure of multiple sheaths in a single vessel, rapid hemostasis (typically under 5 minutes), immediate patient mobility, and reduced access-site complications. Clinical data demonstrates zero hematomas or delayed bleeding in a 138-patient comparative study versus suture-based and collagen-plug competitors. The device improves cath lab workflow efficiency, reduces procedure-related costs per access site, and enhances patient comfort and ambulation recovery. SITESEAL® targets high-volume hospital catheterization labs, ambulatory surgery centers, and EP procedure centers across the United States, competing in the $1.4 billion annual vascular closure market.

Beijing Amsino Medical Inc. (美中双和) is a leading Chinese innovative medical device enterprise specializing in cardiovascular interventional products and drug-device combination solutions. Founded in 1999 and headquartered in Beijing's Chaoyang District, the company has established itself as a pioneering developer in cardiac intervention. With over 200 team members and 25 years of brand heritage, Amsino focuses on R&D, manufacturing, and technical service of cardiovascular, cardiac function, and cardiac structural intervention devices. The company holds 40+ patent applications and delivers differentiated product solutions across the broader vascular intervention landscape, including drug-coated stent systems, balloon expansion catheters for both coronary and peripheral applications, and electrophysiology diagnostic catheters. Amsino is recognized as a National-level "Specialized and New Little Giant" enterprise.

LamaMed Solutions is a Silicon Valley-based medical device development firm specializing in navigating the complete product development lifecycle from concept to commercialization. With a portfolio exceeding 100 issued US and international patents and a proven track record delivering products generating over $1 billion in lifetime revenues, the company provides comprehensive expertise across multiple specialty areas. Core competencies include cardiac and peripheral vascular device development (stent platforms, angioplasty balloons, embolic protection systems), neurovascular technologies (embolic agents and coils), minimally invasive surgical instruments (vessel ligation clips, fascial closure systems), ENT solutions (sinus dilation devices, nasal packing), and dermatologic/plastic surgery devices (breast implants, dermal fillers). The firm offers end-to-end services encompassing product design, prototyping, regulatory pathway planning, device validation, and commercialization strategy, addressing the complex regulatory, clinical, and market challenges inherent in medical device development.

Vein360 specializes in FDA-cleared reprocessed radiofrequency ablation (RFA) and intravascular ultrasound (IVUS) catheters for vein centers. The company delivers cost-effective alternatives to original manufacturer catheters through a validated, environmentally sustainable reprocessing model. Leadership combines surgical expertise, biomedical engineering, and single-use device reprocessing knowledge. All IVUS catheters undergo rigorous multi-point visual inspections and electro-mechanical testing to ensure performance equivalent to new devices. Vein360 helps vein practices significantly reduce procedure costs and medical waste while maintaining clinical safety and device reliability.

Route 92 Medical is a neurovascular intervention medical device company headquartered in San Mateo, California, specializing in endovascular thrombectomy solutions for acute ischemic stroke treatment. The company develops proprietary catheter systems and delivery technologies designed to overcome critical limitations in current neurointervention approaches, including poor navigability through tortuous anatomy, prolonged procedure times, and high failure rates in reaching target lesions. Route 92 Medical's product portfolio includes the FreeClimb Catheter Systems (FreeClimb 54, 70, and 88) powered by Tenzing delivery technology, and the HiPoint Reperfusion System featuring the Monopoint Approach for streamlined super-bore aspiration delivery. These integrated solutions serve interventionalist clinicians and hospitals performing neurovascular procedures, offering comprehensive platforms that eliminate the need for device workarounds and enhance procedural efficiency and clinical outcomes in stroke intervention.